219 related articles for article (PubMed ID: 15993231)
1. Chloramphenicol treatment for acute infective conjunctivitis in children in primary care: a randomised double-blind placebo-controlled trial.
Rose PW; Harnden A; Brueggemann AB; Perera R; Sheikh A; Crook D; Mant D
Lancet; 2005 Jul 2-8; 366(9479):37-43. PubMed ID: 15993231
[TBL] [Abstract][Full Text] [Related]
2. Management of acute infective conjunctivitis.
Drug and Therapeutics Bulletin
Drug Ther Bull; 2011 Jul; 49(7):78-81. PubMed ID: 21733975
[TBL] [Abstract][Full Text] [Related]
3. A randomised controlled trial of management strategies for acute infective conjunctivitis in general practice.
Everitt HA; Little PS; Smith PW
BMJ; 2006 Aug; 333(7563):321. PubMed ID: 16847013
[TBL] [Abstract][Full Text] [Related]
4. A controlled trial of povidone-iodine to treat infectious conjunctivitis in children.
Isenberg SJ; Apt L; Valenton M; Del Signore M; Cubillan L; Labrador MA; Chan P; Berman NG
Am J Ophthalmol; 2002 Nov; 134(5):681-8. PubMed ID: 12429243
[TBL] [Abstract][Full Text] [Related]
5. Effect of Topical Antibiotics on Duration of Acute Infective Conjunctivitis in Children: A Randomized Clinical Trial and a Systematic Review and Meta-analysis.
Honkila M; Koskela U; Kontiokari T; Mattila ML; Kristo A; Valtonen R; Sarlin S; Paalanne N; Ikäheimo I; Pokka T; Uhari M; Renko M; Tapiainen T
JAMA Netw Open; 2022 Oct; 5(10):e2234459. PubMed ID: 36194412
[TBL] [Abstract][Full Text] [Related]
6. Treatment of acute neonatal bacterial conjunctivitis: a comparison of fucidic acid to chloramphenicol eye drops.
Normann EK; Bakken O; Peltola J; Andréasson B; Buhl S; Sigg P; Nielsen K
Acta Ophthalmol Scand; 2002 Apr; 80(2):183-7. PubMed ID: 11952486
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of besifloxacin ophthalmic suspension 0.6% in children and adolescents with bacterial conjunctivitis: a post hoc, subgroup analysis of three randomized, double-masked, parallel-group, multicenter clinical trials.
Comstock TL; Paterno MR; Usner DW; Pichichero ME
Paediatr Drugs; 2010 Apr; 12(2):105-12. PubMed ID: 20218747
[TBL] [Abstract][Full Text] [Related]
8. Conjunctivitis in children.
Normann EK
Lancet; 2005 Jul 2-8; 366(9479):6-7. PubMed ID: 15993210
[No Abstract] [Full Text] [Related]
9. The Efficacy of 1% Chloramphenicol Eye Ointment Versus 2.5% Povidone-Iodine Ophthalmic Solution in Reducing Bacterial Colony in Newborn Conjunctivae.
Bramantyo T; Roeslani RD; Andriansjah A; Sitorus RS
Asia Pac J Ophthalmol (Phila); 2015; 4(3):180-3. PubMed ID: 26065506
[TBL] [Abstract][Full Text] [Related]
10. Short term oral cefixime therapy for treatment of bacterial conjunctivitis.
Wald ER; Greenberg D; Hoberman A
Pediatr Infect Dis J; 2001 Nov; 20(11):1039-42. PubMed ID: 11734708
[TBL] [Abstract][Full Text] [Related]
11. What I learned from DTB: acute infective conjunctivitis?
Cuello-Garcia CA
Arch Dis Child Educ Pract Ed; 2012 Jun; 97(3):113. PubMed ID: 22611126
[No Abstract] [Full Text] [Related]
12. Acute conjunctivitis. A comparison of fusidic acid viscous eye drops and chloramphenicol.
Hørven I
Acta Ophthalmol (Copenh); 1993 Apr; 71(2):165-8. PubMed ID: 8333258
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of besifloxacin ophthalmic suspension 0.6% compared with moxifloxacin ophthalmic solution 0.5% for treating bacterial conjunctivitis.
McDonald MB; Protzko EE; Brunner LS; Morris TW; Haas W; Paterno MR; Comstock TL; Usner DW
Ophthalmology; 2009 Sep; 116(9):1615-1623.e1. PubMed ID: 19643483
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of besifloxacin ophthalmic suspension 0.6% administered twice daily for 3 days in the treatment of bacterial conjunctivitis: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study in adults and children.
Silverstein BE; Allaire C; Bateman KM; Gearinger LS; Morris TW; Comstock TL
Clin Ther; 2011 Jan; 33(1):13-26. PubMed ID: 21397770
[TBL] [Abstract][Full Text] [Related]
15. Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: A multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety study.
Karpecki P; Depaolis M; Hunter JA; White EM; Rigel L; Brunner LS; Usner DW; Paterno MR; Comstock TL
Clin Ther; 2009 Mar; 31(3):514-26. PubMed ID: 19393842
[TBL] [Abstract][Full Text] [Related]
16. [Chloramphenicol eyedrops in acute bacterial conjunctivitis. A comparison of 2 dosage regimes in general practice].
Laerum E; Fiskaadal HJ; Erdal JE; Løberg RM
Tidsskr Nor Laegeforen; 1994 Feb; 114(6):671-3. PubMed ID: 8191447
[TBL] [Abstract][Full Text] [Related]
17. Clinical cure of bacterial conjunctivitis with azithromycin 1%: vehicle-controlled, double-masked clinical trial.
Abelson MB; Heller W; Shapiro AM; Si E; Hsu P; Bowman LM;
Am J Ophthalmol; 2008 Jun; 145(6):959-65. PubMed ID: 18374301
[TBL] [Abstract][Full Text] [Related]
18. A Prospective, Randomized Trial of Povidone-Iodine 0.6% and Dexamethasone 0.1% Ophthalmic Suspension for Acute Bacterial Conjunctivitis.
Ta CN; Raizman MB; Gross RD; Joshi S; Mallick S; Wang Y; Segal B
Am J Ophthalmol; 2020 Jul; 215():56-65. PubMed ID: 32222367
[TBL] [Abstract][Full Text] [Related]
19. Relative impact of clinical evidence and over-the-counter prescribing on topical antibiotic use for acute infective conjunctivitis.
Davis H; Mant D; Scott C; Lasserson D; Rose PW
Br J Gen Pract; 2009 Dec; 59(569):897-900. PubMed ID: 20875257
[TBL] [Abstract][Full Text] [Related]
20. 3-day treatment with azithromycin 1.5% eye drops versus 7-day treatment with tobramycin 0.3% for purulent bacterial conjunctivitis: multicentre, randomised and controlled trial in adults and children.
Cochereau I; Meddeb-Ouertani A; Khairallah M; Amraoui A; Zaghloul K; Pop M; Delval L; Pouliquen P; Tandon R; Garg P; Goldschmidt P; Bourcier T
Br J Ophthalmol; 2007 Apr; 91(4):465-9. PubMed ID: 17050578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
